ICCM Icecure Medical

P/E --
Forward P/E --
Price/Sales 1.234
Beta 0.43
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ Icecure Medical is trading 5.8% down today as oil climbed and Treasury yields rose

Icecure Medical is trading at $1.63, down 5.78%, amid broad risk-off pressure on September 28 after President Trump rejected an Iranian proposal. - Reuters...

🟒 Icecure Medical is trading 10.4% up in pre-market β€” catalyst remains unconfirmed

Icecure Medical is trading 10.4% higher at $1.91, with no confirmed catalyst identified. - It closed at $1.73 on September 24, 2026. - No new company-specific...

πŸ”΄ Icecure Medical is trading 5.35% down today amid elevated Treasury yields and inflation concerns

Icecure Medical is trading 5.35% down now at $1.77 amid elevated Treasury yields and renewed inflation concerns. - No new company-specific announcement was...

πŸ”΄ Icecure Medical is trading 5.1% down today amid rising Treasury yields

Icecure Medical is trading at $1.85, down 5.13%, amid broad risk-asset pressure from rising Treasury yields and renewed inflation concerns. - No new...

🟒 Icecure Medical is trading 7.18% up in pre-market amid continued risk-on sentiment

Icecure Medical is trading 7.18% up at $2.09 alongside the broader September 21, 2026 equity rally. - No new company-specific announcement was identified...

🟒 Icecure Medical is trading 5.64% up in after-hours trading amid a broad market rally

Icecure Medical is trading 5.64% up at $2.06 in after-hours trading amid a strong September 21, 2026 market rally led by technology and growth stocks,...

🟒 Icecure Medical is trading 5.36% up today amid falling oil prices and lower Treasury yields

Icecure Medical is trading 5.36% up at $2.06 as U.S. equities, technology stocks, and cryptocurrency rally on falling oil prices and lower Treasury yields. -...

🟒 Icecure Medical is trading 7.64% up in pre-market today amid broad risk-on sentiment

Icecure Medical is trading at $2.11, up +7.64%, most likely amid broad risk-on sentiment as major U.S. indices rise more than 0.5%. - No new company-specific...

🟒 Icecure Medical is trading 6.53% up in pre-market as Nasdaq futures rise approximately 0.68%

Icecure Medical is trading 6.53% up at $2.12 in pre-market, apparently driven mainly by constructive broader-market sentiment. - No new company-specific...

🟒 Icecure Medical is trading 5.59% up in pre-market amid gains in S&P 500 and Nasdaq futures

Icecure Medical is trading at $2.18 (+5.59%) in pre-market amid broader risk-on sentiment. - No new company-specific announcement or overnight filing was...

πŸ”΄ Icecure Medical is trading 5% down today

Icecure Medical is trading 5.43% down now at $2.09, reversing from its $2.21 close on September 11, 2026, as the immediate catalyst remains unclear. - The...

IceCure Cracks Open China's Fast-Growing Cancer Device Market β€” But Can a $7 Million Company Actually Capitalize?

IceCure Cracks Open China's Fast-Growing Cancer Device Market β€” But Can a $7 Million Company Actually Capitalize?

Shares of IceCure Medical jumped +10% to $2.43 on the heels of a regulatory green light from China's drug authority, defying a soft broader market and...

🟒 Icecure Medical is trading 10% up in pre-market after China’s NMPA approved ProSense for commercialization

Icecure Medical is trading at $2.43, up 9.99%, after China’s NMPA approved ProSense and associated cryoprobes for commercialization. - The Class III...

🟒 Icecure Medical is trading 6% up today after China approved ProSense for commercialization

Icecure Medical is trading at $2.27 (+6.07%) after receiving China NMPA Class III approval for its ProSense cryoablation system and associated cryoprobes. -...

IceCure Medical Secures China Approval for ProSense Tumor-Freezing System

IceCure Medical Secures China Approval for ProSense Tumor-Freezing System

IceCure Medical Ltd. received regulatory approval from China’s National Medical Products Administration (NMPA) for its ProSense cryoablation system. The NMPA...

🟒 Icecure Medical is trading 6.3% up in pre-market β€” catalyst remains unconfirmed

Icecure Medical is trading 6.32% up at $2.24 after rising from the September 9 close of $2.11; the catalyst remains unconfirmed. - No reliable September 10,...

πŸ”΄ Icecure Medical is trading 7.89% down in pre-market

Icecure Medical is trading 7.89% down at $2.10, with no identifiable company-specific announcement on September 2, 2026. - Latest earnings-related news,...

πŸ”΄ Icecure Medical is trading 8.1% down today, extending its recent seven-session decline

Icecure Medical is trading 8.1% down at $2.23, with no clear company-specific catalyst confirmed for August 24, 2026. - The recent seven-session decline took...

πŸ”΄ Icecure Medical is trading 10% down in pre-market β€” no company-specific catalyst confirmed

Icecure Medical is trading 10.32% down at $2.18, with no direct company-specific catalyst confirmed for August 24, 2026. - The decline extends a seven-session...

πŸ”΄ Icecure Medical is trading 7% down in pre-market with no direct catalyst confirmed

Icecure Medical is trading at $2.26 (-7%) after several weaker sessions amid a modestly cautious market, with no direct catalyst confirmed. - No new negative...